No Record Found
No Record Found
Sector
HealthcareOpen
₹1,942Prev. Close
₹1,937.3Turnover(Lac.)
₹1,007.72Day's High
₹1,948.8Day's Low
₹1,908.652 Week's High
₹1,988.952 Week's Low
₹1,272.6Book Value
₹157.23Face Value
₹10Mkt Cap (₹ Cr.)
32,505.6P/E
57.47EPS
33.7Divi. Yield
1.0630 Apr 2026
12:00 AM
AGM
Announcement Date: 30 Apr, 2026
12 Dec 2025
12:00 AM
Bonus
29 Jun 2026
12:00 AM
Board Meeting
Agenda : Audited Result
24 Jul 2026
12:00 AM
Dividend
Dividend Amount: 5
Record Date: 30 Jul, 2026
6 Feb 2025
12:00 AM
EGM
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 167.56 | 83.59 | 83.48 | 83.37 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,305.28 | 2,050.64 | 1,717.24 | 1,606.5 |
Net Worth | 2,472.84 | 2,134.23 | 1,800.72 | 1,689.87 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,872.7 | 1,490.55 | 1,273.59 | 1,024.04 |
yoy growth (%) | 25.63 | 17.03 | 24.36 | 16.12 |
Raw materials | -446.31 | -373.9 | -286.86 | -219.31 |
As % of sales | 23.83 | 25.08 | 22.52 | 21.41 |
Employee costs | -320.22 | -257.43 | -232.06 | -175.08 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 459.39 | 374.04 | 302.75 | 255.31 |
Depreciation | -75.31 | -69.77 | -68 | -31.04 |
Tax paid | -115.34 | -93.93 | -79.57 | -87.33 |
Working capital | -320.46 | 294.61 | 134.44 | 87.45 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 25.63 | 17.03 | 24.36 | 16.12 |
Op profit growth | 25.24 | 24.27 | 28.21 | 11.1 |
EBIT growth | 25.47 | 22.51 | 23.92 | 10.42 |
Net profit growth | 22.82 | 25.5 | 32.85 | 10.16 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 2,762.9 | 2,461.4 | 2,226.6 | 2,016.9 | 2,087.4 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,762.9 | 2,461.4 | 2,226.6 | 2,016.9 | 2,087.4 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 101.3 | 93.4 | 69.2 | 41.7 | 52.5 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 8,766.5 | 80 | 1,26,386.71 | 385.2 | 0.23 | 2,656.1 | 692.92 |
Manipal Health Enterprises Ltd MANIPALHOS | 795 | 234.88 | 1,04,736.91 | 115.53 | 0 | 1,048.3 | 100.51 |
Max Healthcare Institute Ltd MAXHEALTH | 1,005 | 134.75 | 98,495.58 | 167.6 | 0.2 | 782.92 | 91.84 |
Fortis Healthcare Ltd FORTIS | 913.85 | 347.73 | 69,305.16 | 47.78 | 0.11 | 489.45 | 122.24 |
Aster DM Quality Care Ltd ASTERDM | 762.1 | 214.7 | 66,438.87 | -14.3 | 0.23 | 725.73 | 53.52 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman/ED & CEO
Arvind Lal
WTD & Executive Director
Vandana Lal
Lead Independent Non Executive Director
Arun Duggal
Independent Non Exe. Director
Rohit Bhasin
Independent Non Exe. Director
Somya Satsangi
Independent Non Exe. Director
Gurinder Singh Kalra
Independent Non Exe. Director
RAJIT MEHTA
Non Executive Director
Archana Lal Erdmann
Non Executive Director
Rahul Sharma
Company Sec. & Compli. Officer
Vinay Gujral
E-2 Block Sector 18,
Rohini,
New Delhi - 110085
Tel: 91-011-3024 4149
Website: http://www.lalpathlabs.com
Email: cs@lalpathlabs.com
Noble Heights 1st Fl,
Plot NH 2 C-1 Block, LSC Janakpuri,
New Delhi - 110058
Tel: 91-11-41410592/93/94
Website: www.linkintime.co.in
Email: delhi@linkintime.co.in
Summary
Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited, on February 14, 1995 at Delhi. The business of the Partnership Firm, Central Clin...
Read More
Reports by Dr Lal Pathlabs Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
